A new pill for moderate to severe plaque psoriasis
Treatments studied
Part of Skin clinical trials.
This study tests a new oral pill (HSK47388) for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective in reducing the severity and area of psoriasis over 12 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with plaque psoriasis for at least 6 months
- Your psoriasis covers at least 10% of your body (about the size of 10 palms)
- You have moderate to severe psoriasis that needs treatment throughout the body
- You are willing to try a new pill (HSK47388) for 12 weeks or more
- You do not have another type of psoriasis (like pustular or guttate)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental pill called D-2570 for people with moderate to severe plaque psoriasis. It aims to see if the pill can safely improve skin symptoms like redness, scaling, and thickness.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This early-phase study tests an experimental oral tablet (UA026) in people with moderate to severe plaque psoriasis. The purpose is to see how safe and effective the drug is, and how it works in the body.
This study tests an experimental drug, SHR-1139, given as an injection, to see if it can help people with plaque psoriasis who haven't gotten enough relief from other biologic treatments. It aims to improve skin symptoms and quality of life.
This trial tests an oral medication called HS-10374 for people with mild to moderate plaque psoriasis who haven't gotten enough relief from topical treatments. The study will check if the drug is safe and effective at clearing psoriasis patches.
This trial tests a new medication called HSK44459 for people with moderate to severe plaque psoriasis who need systemic therapy (medicine that works throughout the body). The goal is to see if it is safe and effective.
Hear when a new Plaque Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.